Esophageal Adenocarcinoma in the Elderly Limited Benefit of Multimodal Therapy in Octogenarians: Analysis of the German Cancer Registry Group

Markus Kist; Stefan Benz; Ulrich F. Wellner; T. Keck; Jessica Isabel Selig; Thomas Oellerich; Fabian Reinwald; Simone Faißt; Ahmed Bedir; Bianca Franke; Kees Kleihues-van Tol; Freddie Ian Bray; Sylke Ruth Zeißig; Stephan Kersting; Michael Thomaschewski; Richard Hummel; Thaer S. A. Abdalla

doi:10.1016/j.ejso.2025.111214

Back

Esophageal Adenocarcinoma in the Elderly Limited Benefit of Multimodal Therapy in Octogenarians: Analysis of the German Cancer Registry Group

Article 2026 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2026

Current Landscape and Clinical Outcomes of Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma: A Population-based Analysis from the Association of German Tumor Centers

Jannis Duhn, Maxim Riedesser, Thaer S. A. Abdalla, Lennart von Fritsch, Louisa Bolm, Kim Honselmann, Markus Kist, Kees Kleihues-van Tol, Bianca Franke, Fabian Reinwald, Andrea Sackmann, Bernd Holleczek, Anna Krauß, Freddie Ian Bray, Sylke Ruth Zeißig, Tobias Keck, Ulrich F. Wellner, S. Deichmann, Rüdiger Braun

Article2012

A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma

Federica Turati, Irene Tramacere, Carlo La Vecchia, Eva Negri

Article2004

Limited benefit of antiretroviral resistance testing in treatment-experienced patients

John P A Ioannidis, Ermioni T Panidou, Thomas A Trikalinos

Article2006

Survival benefit with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: Meta-analysis

Davide Mauri, Nikolaos P. Polyzos, John P A Ioannidis, Eleni Timotheadou, Nicholas Pavlidis

Article2001

Cancer epidemiology in the elderly

Silvia Franceschi, Carlo La Vecchia